Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares

8 Jun 2012 16:50

null

Transaction in Own Shares

Tate & Lyle PLC (the "Company") announces that on 8 June 2012 it transferred 8,245 ordinary shares in the Company for the purpose of satisfying exercises under the 2000 Executive Share Option Scheme. These shares were previously held in Treasury.

The transfer price per share was 374.50p.

Following the above transfer, the Company holds 2,225,059 ordinary shares in Treasury and has 465,935,460 ordinary shares in issue (excluding Treasury shares).

Lucie GilbertDeputy Company Secretary8 June 2012

Copyright Business Wire 2012

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.